Press Releases
Published: November 19, 2019

Propeller Health users can now access pharmacy services from CVS, Walmart, Kroger and Rite Aid from within the Propeller app

With the expansion of the My Pharmacy feature, patients can use Propeller to refill prescriptions with five of the seven largest pharmaceutical providers in the U.S. 

MADISON, Wis., November 19, 2019 — Propeller Health, a leading digital health company dedicated to the management of asthma and chronic obstructive pulmonary disease (COPD), announced that users are now able to access pharmacy services from CVS, Walmart, Kroger and Rite Aid directly from the Propeller app. 

In January 2019, Propeller announced the launch of My Pharmacy, an in-app feature that allows users to manage their prescription refills for asthma and COPD and locate a nearby pharmacy from the Propeller app. 

My Pharmacy launched initially with Walgreens, and has now expanded to include CVS, Walmart, Kroger and Rite Aid, five of the seven largest pharmaceutical providers in the U.S. representing more than 50 percent of total U.S. market share for prescription pharmaceuticals, according to Drug Channels Institute.

“We know that medication management can be an additional burden for people living with asthma and COPD,” said Greg Tracy, chief technology officer of Propeller Health. “We hope that creating a convenient way to refill prescriptions and locate nearby pharmacies from the Propeller app makes life easier for our users.”

Propeller is a digital health tool that helps people with asthma or COPD manage their condition in partnership with their doctor. Propeller sensors attach to patients’ existing inhalers and deliver insights on medication use, symptom triggers and environmental factors to the Propeller app on their smartphone, which they can then share with their clinician to help inform their treatment plan.

The update will also allow users to select their preferred pharmacy to display in the Records tab of the app. Propeller users can access the newly connected pharmacy services in the app starting this week.

About Propeller Health

Propeller Health is a leading digital health company dedicated to making life better for every person with chronic respiratory disease. Propeller creates products to more effectively treat chronic respiratory disease and improve clinical outcomes for patients through connectivity, analytics, and companion digital experiences. The Propeller platform is used by patients, physicians and healthcare organizations in the United States, Europe and Asia. Propeller Health is a wholly owned subsidiary of ResMed (NYSE: RMD, ASX: RMD). For more information, visit

You Might Also Like

Propeller Health Named a Winner of Fierce Healthcare Innovation Awards 2022

Propeller Health’s precision digital health platform wins the Clinical Information Management category of the Fierce Healthcare Innovation Awards 2022. The platform enables physicians and care teams to proactively identify at-risk patients in between routine visits and provide more timely clinical interventions.

MADISON, WI, November 15, 2022 – Propeller Health, a leader in precision digital health, today announces its platform for chronic condition management is a Fierce Healthcare Innovation Awards 2022 winner. The program showcases outstanding innovation that is driving improvements and transforming the industry. The Propeller Digital Health Platform for Chronic Condition Management (The Propeller Platform”) enables proactive clinical care by collecting objective patient data and displaying resulting insights directly within a provider’s native workflow. 

At Propeller, data itself is only the beginning – activating it is what powers patient care,” said Susa Monacelli, Propeller Health General Manager. By surfacing the data within clinicians' existing workflow through EHR integrations, we enable their treatment decisions and help identify at-risk patients. Patient self-management coupled with proactive clinician intervention helps improve clinical outcomes and, in turn, economic value for health systems, payers, and patients. Our focus is to do this across connected medications and therapies to change healthcare at scale.”

Propeller Health accelerates push towards value-based care with new digital health solutions for patients, providers and health systems

Announces integrations with multiple leading Electronic Health Record (EHR) systems, introduces a new solution to enable Remote Therapeutic Monitoring (RTM) by healthcare providers, and launches digital platform updates to enable respiratory care at home, in-clinic, and on-the-go.

MIAMI, March 7, 2022 – Propeller Health, a leader in digital health for asthma and chronic obstructive pulmonary disease (COPD), today announced three exciting updates and new solutions to bring its clinically proven, FDA-cleared platform to more patients, providers and health systems.

Integrations expand the reach of Propeller’s digital platform to more health systems
Propeller Health research shows digital health programs help improve outcomes for vulnerable and underserved populations with chronic respiratory conditions
News Announcement at HLTH 2021, Boston MA, October 18, 2021 MADISON, Wisconsin, October 18, 2021 - Propeller Health, a leader in digital health and therapeutics for asthma and chronic obstructive pulmonary disease (COPD), revealed two recent studies that showed that digital health interventions alongside appropriate care resources and tools can expand access and improve outcomes for elderly and underserved populations. Propeller’s digital health platform includes Bluetooth® connected inhaler sensors that chime medication reminders and record inhaler medication use, paired with a smartphone app that provides education and feedback to support self-management. In a study1 conducted in partnership with Desert Oasis Healthcare, Propeller evaluated the effect of digital health intervention on healthcare resource utilization and medication use in patients with COPD. 56 patients with COPD, average age 75, were enrolled by their clinical pharmacists, who received alerts through Propeller’s clinician portal whenever patients showed low controller medication adherence or high rescue inhaler use.